BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26808577)

  • 41. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma.
    Sun K; Jia Z; Duan R; Yan Z; Jin Z; Yan L; Li Q; Yang J
    Biochem Biophys Res Commun; 2019 Mar; 510(3):416-420. PubMed ID: 30717973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3.
    Zhao J; Lei T; Xu C; Li H; Ma W; Yang Y; Fan S; Liu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):439-44. PubMed ID: 23916610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.
    Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A
    Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
    Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
    Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1].
    Lei K; Xie W; Sun T; Liu Y; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):712-717. PubMed ID: 35673915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.
    Conceição AL; Da Silva CT; Badial RM; Valsechi MC; Stuqui B; Gonçalves JD; Jasiulionis MG; De Freitas Calmon M; Rahal P
    Oncol Rep; 2017 Mar; 37(3):1487-1496. PubMed ID: 28184927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB.
    Niu S; Ma X; Zhang Y; Liu YN; Chen X; Gong H; Yao Y; Liu K; Zhang X
    PLoS One; 2018; 13(2):e0192790. PubMed ID: 29474434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1.
    Yang FQ; Zhang HM; Chen SJ; Yan Y; Zheng JH
    PLoS One; 2015; 10(3):e0120258. PubMed ID: 25793370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
    Xiao W; Wang C; Chen K; Wang T; Xing J; Zhang X; Wang X
    EBioMedicine; 2020 Jan; 51():102622. PubMed ID: 31901870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC.
    Jingushi K; Ueda Y; Kitae K; Hase H; Egawa H; Ohshio I; Kawakami R; Kashiwagi Y; Tsukada Y; Kobayashi T; Nakata W; Fujita K; Uemura M; Nonomura N; Tsujikawa K
    Mol Cancer Res; 2015 Mar; 13(3):565-74. PubMed ID: 25381221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-532-3p suppresses cell viability, migration and invasion of clear cell renal cell carcinoma through targeting TROAP.
    Gao B; Wang L; Zhang Y; Zhang N; Han M; Liu H; Sun D; Liu Y
    Cell Cycle; 2021 Aug; 20(16):1578-1588. PubMed ID: 34287099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor suppressive microRNA‑429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma.
    Chen D; Li Y; Li Y; Jin L; Su Z; Yu Z; Yang S; Mao X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1361-6. PubMed ID: 26647818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells.
    Xiao X; Tang C; Xiao S; Fu C; Yu P
    Oncol Res; 2013; 20(11):537-44. PubMed ID: 24063284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNAs MiR-15a and MiR-26a cooperatively regulate O-GlcNAc-transferase to control proliferation in clear cell renal cell carcinoma.
    Kalantzakos TJ; Sullivan TB; Sebel LE; Canes D; Burks EJ; Moinzadeh A; Rieger-Christ KM
    Cancer Biomark; 2021; 30(3):343-351. PubMed ID: 33337348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miRNA-27b-3p/TPX2 Axis Regulates Clear Cell Renal Cell Carcinoma Cell Proliferation, Invasion and Migration.
    Liu N; Jiang Y; Chen S; Pan F; Tang Y; Tan X
    Crit Rev Eukaryot Gene Expr; 2024; 34(1):27-39. PubMed ID: 37824390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
    Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
    Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.
    Song S; Long M; Yu G; Cheng Y; Yang Q; Liu J; Wang Y; Sheng J; Wang L; Wang Z; Xu B
    J Cell Mol Med; 2019 Oct; 23(10):6755-6765. PubMed ID: 31342628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
    Wang X; Jiang F; Song H; Li X; Xian J; Gu X
    Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.